pI: 7.3893 |
Length (AA): 432 |
MW (Da): 45528 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 432 | 4dwr (B) | 46 | 481 | 54.00 | 0 | 1 | 1.70119 | -0.99 |
2 | 432 | 2epg (A) | 45 | 476 | 55.00 | 0 | 1 | 1.57219 | -0.6 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Dormant phase, Dormant phase. | hasan murphy |
hasan | Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis. |
murphy | Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. |
Ortholog group members (OG5_127467)
Species | Accession | Gene Product |
---|---|---|
Babesia bovis | BBOV_III007770 | uncharacterized protein family UPF0027 family protein |
Brugia malayi | Bm1_49220 | Hypothetical UPF0027 protein F16A11.2 in chromosome I, putative |
Caenorhabditis elegans | CELE_F16A11.2 | Protein F16A11.2 |
Dictyostelium discoideum | DDB_G0278481 | UPF0027 family protein |
Drosophila melanogaster | Dmel_CG9987 | CG9987 gene product from transcript CG9987-RA |
Escherichia coli | b3421 | RNA-splicing ligase |
Echinococcus granulosus | EgrG_001000200 | tRNA splicing ligase RtcB |
Entamoeba histolytica | EHI_169260 | hypothetical protein, conserved |
Entamoeba histolytica | EHI_184560 | hypothetical protein, conserved |
Echinococcus multilocularis | EmuJ_001000200 | tRNA splicing ligase RtcB |
Giardia lamblia | GL50803_23602 | RTCB PROTEIN |
Homo sapiens | ENSG00000100220 | RNA 2',3'-cyclic phosphate and 5'-OH ligase |
Leishmania braziliensis | LbrM.33.0570 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_330580.1 | tRNA-splicing ligase RtcB, putative |
Leishmania infantum | LinJ.33.0580 | hypothetical protein, conserved |
Leishmania major | LmjF.33.0560 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.32.0560 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_10041 | hypothetical protein |
Loa Loa (eye worm) | LOAG_09873 | hypothetical protein |
Mus musculus | ENSMUSG00000001783 | RNA 2',3'-cyclic phosphate and 5'-OH ligase |
Mycobacterium tuberculosis | Rv2631 | Conserved hypothetical protein |
Neospora caninum | NCLIV_002530 | UPF0027 protein PH1602, related |
Plasmodium berghei | PBANKA_0941200 | tRNA-splicing ligase RtcB, putative |
Plasmodium falciparum | PF3D7_1105700 | tRNA-splicing ligase RtcB, putative |
Plasmodium falciparum | PF3D7_1222000 | tRNA-splicing ligase RtcB, putative |
Plasmodium knowlesi | PKNH_0903300 | tRNA-splicing ligase RtcB, putative |
Plasmodium knowlesi | PKNH_1441100 | tRNA-splicing ligase RtcB, putative |
Plasmodium vivax | PVX_123735 | hypothetical protein, conserved |
Plasmodium vivax | PVX_090965 | tRNA-splicing ligase RtcB, putative |
Plasmodium yoelii | PY03374 | Uncharacterized protein family UPF0027 |
Plasmodium yoelii | PY03776 | Uncharacterized protein family UPF0027 |
Schistosoma japonicum | Sjp_0217320 | similar to UPF0027 protein F16A11.2, putative |
Schistosoma japonicum | Sjp_0102950 | similar to UPF0027 protein F16A11.2, putative |
Schistosoma japonicum | Sjp_0309710 | similar to UPF0027 protein F16A11.2, putative |
Schistosoma mansoni | Smp_074870 | hypothetical protein |
Schmidtea mediterranea | mk4.000891.01 | tRNA-splicing ligase RtcB homolog |
Trypanosoma brucei gambiense | Tbg972.10.13520 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.10.11190 | tRNA-splicing ligase RtcB, putative |
Trypanosoma congolense | TcIL3000_10_10120 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.509641.20 | tRNA-splicing ligase RtcB, putative |
Trypanosoma cruzi | TcCLB.507711.140 | tRNA-splicing ligase RtcB, putative |
Toxoplasma gondii | TGME49_207450 | DNA segment, Chr 10, Wayne State University 52, expressed family protein |
Theileria parva | TP04_0661 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_302250 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_218190 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_285750 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_386070 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_164050 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_164040 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu2677 this record | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb927.10.11190 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.11190 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.11190 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.11190 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b3421 | Escherichia coli | non-essential | goodall |
CELE_F16A11.2 | Caenorhabditis elegans | slow growth | wormbase |
TGME49_207450 | Toxoplasma gondii | Probably non-essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.2